HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
This Quarter Return
-0.87%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.07B
AUM Growth
+$1.07B
(+165%)
Cap. Flow
+$656M
Cap. Flow
% of AUM
61.06%
Top 10 Holdings %
Top 10 Hldgs %
97.69%
Holding
19
New
2
Increased
4
Reduced
6
Closed
1
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$374M |
| 2 |
Palo Alto Networks
PANW
|
$254M |
| 3 |
Booking.com
BKNG
|
$123M |
| 4 |
Adobe
ADBE
|
$11.9M |
| 5 |
Fulcrum Therapeutics
FULC
|
$2.73M |
Top Sells
| 1 |
Apple
AAPL
|
$100M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$7.64M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$921K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$728K |
| 5 |
Vanguard World Funds Extended Duration ETF
EDV
|
$396K |
Sector Composition
| 1 | Communication Services | 49.68% |
| 2 | Technology | 25.8% |
| 3 | Consumer Discretionary | 16.19% |
| 4 | Healthcare | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Meta Platforms (Facebook)
META
$1.86T
| $404M | 37.61% | 2,268,011 +2,097,930 | +1,233% | +$374M |
|
|
2
Palo Alto Networks
PANW
$127B
| $265M | 24.69% | 1,300,615 +1,246,609 | +2,308% | +$254M |
|
|
3
Booking.com
BKNG
$181B
| $174M | 16.19% | 88,597 +62,923 | +245% | +$123M |
|
|
4
Alphabet (Google) Class A
GOOGL
$2.57T
| $130M | 12.07% | 106,093 -6,253 | -6% | -$7.64M |
|
|
5
iShares Core S&P 500 ETF
IVV
$662B
| $20.6M | 1.92% | 69,061 -3,086 | -4% | -$921K |
|
6
SPDR Gold Trust
GLD
$107B
| $14.1M | 1.31% | 101,355 -112 | -0.1% | -$15.6K |
|
|
7
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $12.8M | 1.19% | 311,456 -17,711 | -5% | -$728K |
|
|
8
Adobe
ADBE
$151B
| $11.9M | 1.11% | +43,222 | New | +$11.9M |
|
9
Invesco QQQ Trust
QQQ
$364B
| $9.54M | 0.89% | 50,517 +43 | +0.1% | +$8.12K |
|
10
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $7.56M | 0.7% | 187,728 | – | – |
|
|
11
Vanguard World Funds Extended Duration ETF
EDV
$3.49B
| $7.27M | 0.68% | 51,442 -2,805 | -5% | -$396K |
|
12
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $5M | 0.47% | 25,885 -874 | -3% | -$169K |
|
13
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $4.55M | 0.42% | 58,484 | – | – |
|
14
Dianthus Therapeutics
DNTH
$759M
| $3.41M | 0.32% | 332,610 | – | – |
|
|
15
Fulcrum Therapeutics
FULC
$351M
| $2.73M | 0.25% | +410,714 | New | +$2.73M |
|
|
NTGN
16
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $870K | 0.08% | 505,871 | – | – |
|
|
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $679K | 0.06% | 640,595 | – | – |
|
18
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $342K | 0.03% | 2,858 | – | – |
|
|
19
Apple
AAPL
$3.45T
| – | – | -506,683 | Closed | -$100M |
|